526 related articles for article (PubMed ID: 18617779)
1. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
3. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
[TBL] [Abstract][Full Text] [Related]
4. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
[TBL] [Abstract][Full Text] [Related]
5. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup.
Binion DG; Kugathasan S; Dwinell MB
Am J Gastroenterol; 2006 Jan; 101(1):107-9. PubMed ID: 16405541
[TBL] [Abstract][Full Text] [Related]
6. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
7. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
Ernst A; Jacobsen B; Østergaard M; Okkels H; Andersen V; Dagiliene E; Pedersen IS; Thorsgaard N; Drewes AM; Krarup HB
Scand J Gastroenterol; 2007 Dec; 42(12):1445-51. PubMed ID: 17852840
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation.
Büning C; Genschel J; Bühner S; Krüger S; Kling K; Dignass A; Baier P; Bochow B; Ockenga J; Schmidt HH; Lochs H
Aliment Pharmacol Ther; 2004 May; 19(10):1073-8. PubMed ID: 15142196
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
Barreiro-de Acosta M; Peña AS
Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
[TBL] [Abstract][Full Text] [Related]
10. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease.
Tomer G; Ceballos C; Concepcion E; Benkov KJ
Am J Gastroenterol; 2003 Nov; 98(11):2479-84. PubMed ID: 14638352
[TBL] [Abstract][Full Text] [Related]
11. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
[TBL] [Abstract][Full Text] [Related]
12. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?
Buhner S; Buning C; Genschel J; Kling K; Herrmann D; Dignass A; Kuechler I; Krueger S; Schmidt HH; Lochs H
Gut; 2006 Mar; 55(3):342-7. PubMed ID: 16000642
[TBL] [Abstract][Full Text] [Related]
13. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
14. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
[TBL] [Abstract][Full Text] [Related]
15. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
[TBL] [Abstract][Full Text] [Related]
16. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population.
Núñez C; Barreiro M; Domínguez-Muñoz JE; Lorenzo A; Zapata C; Peña AS
Am J Gastroenterol; 2004 Mar; 99(3):450-6. PubMed ID: 15056084
[TBL] [Abstract][Full Text] [Related]
17. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs.
Hradsky O; Lenicek M; Dusatkova P; Bronsky J; Nevoral J; Valtrova V; Kotalova R; Szitanyi P; Petro R; Starzykova V; Bortlik M; Vitek L; Lukas M; Cinek O
Tissue Antigens; 2008 Jun; 71(6):538-47. PubMed ID: 18489434
[TBL] [Abstract][Full Text] [Related]
18. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.
Laukens D; Peeters H; Marichal D; Vander Cruyssen B; Mielants H; Elewaut D; Demetter P; Cuvelier C; Van Den Berghe M; Rottiers P; Veys EM; Remaut E; Steidler L; De Keyser F; De Vos M
Ann Rheum Dis; 2005 Jun; 64(6):930-5. PubMed ID: 15539413
[TBL] [Abstract][Full Text] [Related]
19. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
[TBL] [Abstract][Full Text] [Related]
20. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
